secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001493152-23-043666
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed 1-for-15 reverse split Dec 7; declares Lucid dividend of ~3.3M shares
----------------------------------------------------------------------------

- Reverse split at 1-for-15 effective Dec 7, 2023; authorized common reduced from 250M to 50M shares.
- Dividend of ~3.3M Lucid Diagnostics (LUCD) shares to PAVmed holders of record Jan 15, 2024; distribution within 30 days.
- Series Z warrants maturity extended by 12 months to April 30, 2025; exercise price and shares adjusted proportionately.
- Reverse split aims to regain Nasdaq minimum $1 bid price compliance; company had until Dec 26, 2023.
- Accredited investor holding convertible notes waived as-converted participation in Lucid dividend.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223043666/0001493152-23-043666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223043666/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer